High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins

Diabetes

Volumn 59, Issue 12, 2010, Pages 3192-3197

  Arnold, Edith ^a   Rivera, José C ^a   Thebault, Stéphanie ^a   Moreno Páramo, Daniel ^b   Quiroz Mercado, Hugo ^b,c,d   Quintanar Stéphano, Andrés ^e   Binart, Nadine ^f   De La Escalera, Gonzalo Martínez ^a   Clapp, Carmen ^a  

^a INSTITUTO DE MATEMÁTICAS   (Mexico)

^b HOSPITAL DR LUIS SÁNCHEZ BULNES   (Mexico)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; PROLACTIN; PROLACTIN RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASOINHIBIN DERIVATIVE;

ADENOHYPOPHYSIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; GENE DELETION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS GRAFT; KIDNEY CAPSULE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLIFERATIVE RETINOPATHY; RAT; RETINA BLOOD VESSEL; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL MARKERS; CELL CYCLE PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS; HYPERPROLACTINEMIA; MALE; MICE; MIDDLE AGED; PROLACTIN; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650064127     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0873     Document Type: Article

References (25)

1. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003;19:442-455
2. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007;298:902-916
3. Clapp C, Thebault S, Jeziorski MC, Martínez De La Escalera G. Peptide hormone regulation of angiogenesis. Physiol Rev 2009;89:1177-1215
4. Pan H, Nguyen NQ, Yoshida H, Bentzien F, Shaw LC, Rentier-Delrue F, Martial JA, Weiner R, Struman I, Grant MB. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 2004;45:2413-2419
5. García C, Aranda J, Arnold E, Thébault S, Macotela Y, López-Casillas F, Mendoza V, Quiroz-Mercado H, Hernández-Montiel HL, Lin SH, de la Escalera GM, Clapp C. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest 2008;118:2291-2300
6. Aranda J, Rivera JC, Jeziorski MC, Riesgo-Escovar J, Nava G, López-Barrera F, Quiróz-Mercado H, Berger P, Martínez de la Escalera G, Clapp C. Prolactins are natural inhibitors of angiogenesis in the retina. Invest Ophthalmol Vis Sci 2005;46:2947-2953
7. O'Steen WK, Sundberg DK. Patterns of radioactivity in the eyes of rats after injection of iodinated prolactin. Ophthalmic Res 1982;14:54-62
8. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682
9. Adler RA. The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia. Endocr Rev 1986;7:302-313
10. Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058-1063
11. Li B, Zhang HQ, Shi Y, Min YB, Lin SF, Wu KL, Hu J, Tang SB. Overexpression of nuclear transport factor 2 may protect against diabetic retinopathy. Mol Vis 2009;15:861-869
12. Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 2002;110:973-981
13. Mestriner AC, Haddad A. Horseradish peroxidase: a reliable or a misleading tool for the investigations on the origin of the proteins of the aqueous humor? Cell Tissue Res 1997;289:85-96
14. Mooradian AD, Morley JE, Billington CJ, Slag MF, Elson MK, Shafer RB. Hyperprolactinaemia in male diabetics. Postgrad Med J 1985;61:11-14
15. Harter M, Balarac N, Pourcher P, Koslowski JM, Krebs B, Ramaioli A. Diabetic retinopathy and prolactin. Lancet 1976;2:961-962
16. Cerasola GA, Donatelli M, Sinagra D, Russo V, Amico LM, Lodato G. Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus. Acta Diabetol Lat 1981;18:319-328
17. Froland A, Hagen C, Lauritzen E. Diabetic retinopathy and prolactin. Lancet 1977;1:45
18. Triebel J, Huefner M, Ramadori G. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy. Eur J Endocrinol 2009;161:345-353
19. Mangurian LP, Walsh RJ, Posner BI. Prolactin enhancement of its own uptake at the choroid plexus. Endocrinology 1992;131:698-702
20. Seddiki T, Delpal S, Aubourg A, Durand G, Ollivier-Bousquet M. Endocytic prolactin routes to the secretory pathway in lactating mammary epithelial cells. Biol Cell 2002;94:173-185
21. Fleenor DE, Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology 2001;142:2805-2810
22. Huang C, Snider F, Cross JC. Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 2009;150:1618-1626
23. Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev 2009;5:151-156
24. Larinkari J, Laatikainen L, Ranta T, Mörönen P, Pesonen K, Laatikainen T. Metabolic control and serum hormone levels in relation to retinopathy in diabetic pregnancy. Diabetologia 1982;22:327-332
25. Moloney JB, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982;93:745-756